Neurocrine Biosciences (NBIX) Net Margin (2016 - 2025)
Historic Net Margin for Neurocrine Biosciences (NBIX) over the last 14 years, with Q4 2025 value amounting to 19.08%.
- Neurocrine Biosciences' Net Margin rose 26600.0% to 19.08% in Q4 2025 from the same period last year, while for Dec 2025 it was 16.73%, marking a year-over-year increase of 22400.0%. This contributed to the annual value of 16.73% for FY2025, which is 22400.0% up from last year.
- As of Q4 2025, Neurocrine Biosciences' Net Margin stood at 19.08%, which was up 26600.0% from 26.36% recorded in Q3 2025.
- Over the past 5 years, Neurocrine Biosciences' Net Margin peaked at 28.67% during Q4 2023, and registered a low of 18.22% during Q1 2023.
- In the last 4 years, Neurocrine Biosciences' Net Margin had a median value of 15.64% in 2025 and averaged 13.55%.
- Its Net Margin has fluctuated over the past 5 years, first surged by 298800bps in 2021, then plummeted by -122400bps in 2024.
- Neurocrine Biosciences' Net Margin (Quarter) stood at 7.6% in 2021, then surged by 277bps to 28.67% in 2023, then tumbled by -43bps to 16.43% in 2024, then increased by 16bps to 19.08% in 2025.
- Its Net Margin stands at 19.08% for Q4 2025, versus 26.36% for Q3 2025 and 15.64% for Q2 2025.